Fidaxomicin (OPT-80) for the treatment of Clostridium difficile infection

Author: Miller Mark  

Publisher: Informa Healthcare

ISSN: 1465-6566

Source: Expert Opinion on Pharmacotherapy, Vol.11, Iss.9, 2010-06, pp. : 1569-1578

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract